Norway vs Timor-Leste: Treatment success rate for patients treated for MDR-TB
Norway
91.0%
in 2022
Timor-Leste
95.0%
in 2022
Norway rank
21st
Timor-Leste rank
18th
Treatment success rate for patients treated for MDR-TB over time
- Norway
- Timor-Leste
How they compare
Timor-Leste currently reports 95.0% against 91.0% in Norway, a difference of 4.0%.
The two have swapped places 7 times across 14 shared years of data; in 2009 it was Norway ahead.
Norway ranks 21st and Timor-Leste ranks 18th of 163 countries.
Across the 3 decades both report, Norway averaged higher in 1 and Timor-Leste in 2.
Head to head by decade
| Decade | Norway | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.0% | 0.0% | 63.0% | Norway |
| 2010s | 74.4% | 75.0% | 0.6% | Timor-Leste |
| 2020s | 86.0% | 86.7% | 0.7% | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Norway or Timor-Leste?
- Timor-Leste, at 95.0% against 91.0% in Norway as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Norway and Timor-Leste?
- 4.0%, with Timor-Leste ahead.
- How many years of comparable data are there for Norway and Timor-Leste?
- 14 years are reported by both, from 2009 to 2022.
- How do Norway and Timor-Leste rank globally for treatment success rate for patients treated for mdr-tb?
- Norway ranks 21st and Timor-Leste ranks 18th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.